Psychotomimetic

A drug with psychotomimetic (also known as psychotogenic) actions mimics the symptoms of psychosis, including delusions and/or delirium, as opposed to only hallucinations. Psychotomimesis is the onset of psychotic symptoms following the administration of such a drug.

Some rarely used drugs of the opioid class have psychotomimetic effects. Particularly, mixed kappa receptor agonist mu receptor antagonist opioid analgesics can cause dose-related psychotomimesis.^[1] This adverse effect, incidence 1–2%, limits their use. Pentazocine and butorphanol fall under this opioid class.^[2]

There is evidence that cannabinoids are psychotomimetic,^[3] especially delta-9-tetrahydrocannabinol (Δ⁹-THC). D'Souza et al. (2004) found that intravenous THC produced effects that resemble schizophrenia in both the positive symptoms (hallucinations, delusions, paranoia, and disorganized thinking) and negative symptoms (avolition, asociality, apathy, alogia, and anhedonia).^[4] Certain strains of cannabis may be more psychotomimetic than others, probably due to the action of cannabidiol (CBD), which inhibits P450 3A11's metabolic conversion of THC to 11-Hydroxy-THC, which is four times more psychoactive.^[5]^p. 39

Carl Sagan used the word "psychotomimetic" in his anonymous article "Mr.X"^[6] to describe the effects of cannabis, writing that "I smile, or sometimes even laugh out loud at the pictures on the insides of my eyelids. In this sense, I suppose cannabis is psychotomimetic, but I find none of the panic or terror that accompanies some psychoses."

Psychostimulants, such as cocaine and amphetamines are known to produce psychotic symptoms similar to paranoid schizophrenia and manic-depressive psychosis.

Synthetic cathinones such as bath salts as well as dissociatives drugs such as PCP also elicit psychotic behavior in its users which may result in medical intervention.

Drugs and substances such as BZ (QNB) also fall into the class of psychotomimetics.

List of psychotomimetic drugs[]

Substances that can induce psychotomimetic effects include:

Alcohol (chronic/excessive use)
Amantadine
Amphetamine
Amylone
Atropine
Benztropine
Benzydamine
Benzylpiperazine
Bromocriptine
Bupropion
Butorphanol
Cathinone
Cocaine
Cyclazocine
Desoxypipradrol
Dimethyltryptamine (DMT)
Diphenhydramine (DPH)
Doxylamine
Efavirenz
Enadoline
Ephedrine
Ergine
Ethylone
Ibogaine
Inhalants
Ketamine
Ketazocine
Levorphanol
Lysergic acid diethylamide (LSD)
Meperidine
Mephedrone
Mescaline
Methamphetamine
Methcathinone
Methorphan
Methoxetamine (MXE)
Methylenedioxyamphetamine (MDA)
Methylenedioxymethamphetamine (MDMA)
Methylenedioxy-N-ethylamphetamine (MDEA)
Methylenedioxypyrovalerone (MDPV)
Methylone
Methylphenidate
Montelukast
Myristicin
N-Ethylpentylone
Pentazocine
Phencyclidine (PCP)
Pramipexole
Prolintane
Prolintanone
Propylhexedrine
Psilocybin
Pyrovalerone
Quinuclidinyl benzilate (QNB)
Rotigotine
Salvinorin A
Scopolamine
Synthetic cannabinoids
Tetrahydrocannabinol (THC)
Tramadol
Zolpidem
Zopiclone

References[]

^ Pfeiffer (1986). "Psychotomimesis mediated by kappa opiate receptors". Science. 233 (4765): 774–776. Bibcode:1986Sci...233..774P. doi:10.1126/science.3016896. PMID 3016896.
^ Musacchio JM (1990). "The psychotomimetic effects of opiates and the sigma receptor". Neuropsychopharmacology. 3 (3): 191–200. PMID 2163646.
^ Sewell R. A.; Ranganathan M.; D'Souza D. C. (2009). "Cannabinoids and psychosis". International Review of Psychiatry. 21 (2): 152–162. doi:10.1080/09540260902782802. PMID 19367509.
^ D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH (2004). "The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis" (PDF). Neuropsychopharmacology. 29 (8): 1558–1572. doi:10.1038/sj.npp.1300496. PMID 15173844.
^ Brenneisen R. Chemistry and analysis of phytocannabinoids and other Cannabis constituents. In: ElSohly MA (ed). Marijuana and the cannabinoids. Humana Press Inc: Totowa, New Jersey, 2007.
^ Sagan, Carl. "Mr. X". Marijuana-Uses.com. Retrieved November 8, 2012.

This drug article relating to the nervous system is a stub. You can help Wikipedia by .

[1] Pfeiffer (1986). "Psychotomimesis mediated by kappa opiate receptors". Science. 233 (4765): 774–776. Bibcode:1986Sci...233..774P. doi:10.1126/science.3016896. PMID 3016896.

[2] Musacchio JM (1990). "The psychotomimetic effects of opiates and the sigma receptor". Neuropsychopharmacology. 3 (3): 191–200. PMID 2163646.

[3] Sewell R. A.; Ranganathan M.; D'Souza D. C. (2009). "Cannabinoids and psychosis". International Review of Psychiatry. 21 (2): 152–162. doi:10.1080/09540260902782802. PMID 19367509.

[4] D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH (2004). "The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis" (PDF). Neuropsychopharmacology. 29 (8): 1558–1572. doi:10.1038/sj.npp.1300496. PMID 15173844.

[5] Brenneisen R. Chemistry and analysis of phytocannabinoids and other Cannabis constituents. In: ElSohly MA (ed). Marijuana and the cannabinoids. Humana Press Inc: Totowa, New Jersey, 2007.

[6] Sagan, Carl. "Mr. X". Marijuana-Uses.com. Retrieved November 8, 2012.

[1]

[2]

[3]

[4]

[5]

[6]

Psychotomimetic

List of psychotomimetic drugs[]

See also[]

References[]